nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2005-9-4-98-103nefr-730Research ArticleПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИPROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGYНАСЛЕДСТВЕННЫЕ ФОРМЫ НЕФРОГЕННОГО НЕСАХАРНОГО ДИАБЕТАHEREDITARY FORMS OF NEPHROGENIC DIABETES INSIPIDUSСмирноваН. Н.SmirnovaN. N.
Кафедра педиатрии
Санкт-Петербургский государственный медицинский университет им.акад. И.П. ПавловаRussian Federation2005100420059498103Copyright © Смирнова Н.Н., 20052005Смирнова Н.Н.Smirnova N.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/730
Наследственные формы нефрогенного несахарного диабета.
Hereditary forms of nephrogenic diabetes insipidus.
нефрогенный несахарный диабетаргининвазопрессинрецепторыаквапориныnephrogenic diabetes insipidusargininevasopressinereceptorsaquaporinesReferencesБагров ЯЮ. Нефрогенный несахарный диабет: пато генез и клинические варианты. Нефрология 1997;1(3): 1117Багров ЯЮ. Нефрогенный несахарный диабет: пато генез и клинические варианты. Нефрология 1997;1(3): 1117Van Lieburg AF, Knoers NV, Monnens LA. Congenital nephrogenic diabetes insipidus: a difficult diagnosis? Ned Tijdschr Geneeskd 1997; 141 (13): 609 – 612Van Lieburg AF, Knoers NV, Monnens LA. Congenital nephrogenic diabetes insipidus: a difficult diagnosis? Ned Tijdschr Geneeskd 1997; 141 (13): 609 – 612Arthus MF et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with Xlinked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000; 11 (6):1044 – 1054Arthus MF et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with Xlinked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000; 11 (6):1044 – 1054Manning M, Cheng LL, Stoev S et al. Neurohypophysis: recent progress of vasopressin and oxytocin research. Amsterdam, 1995: 21 – 38Manning M, Cheng LL, Stoev S et al. Neurohypophysis: recent progress of vasopressin and oxytocin research. Amsterdam, 1995: 21 – 38Иванова ЛН. Вазопрессин: клеточные и молекуляр ные аспекты антидиуретического действия. Вестник РАМН 1999; (3): 40 – 45Иванова ЛН. Вазопрессин: клеточные и молекуляр ные аспекты антидиуретического действия. Вестник РАМН 1999; (3): 40 – 45Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001; 63: 607 – 630Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001; 63: 607 – 630Ishikawa SE. Nephrogenic diabetes insipidus with mutation of vasopressin V2 receptors and aquaporin2. Nippon Rinsho 2002; 60 (2): 350 – 355Ishikawa SE. Nephrogenic diabetes insipidus with mutation of vasopressin V2 receptors and aquaporin2. Nippon Rinsho 2002; 60 (2): 350 – 355Kamsteeg EJ, Deen PM, van Os CH. Defective processing and trafficking of water channels in nephrogenic diabetes insipidus. Exp Nephrol 2000; 8 (6): 326 – 331Kamsteeg EJ, Deen PM, van Os CH. Defective processing and trafficking of water channels in nephrogenic diabetes insipidus. Exp Nephrol 2000; 8 (6): 326 – 331Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001;16 (12): 1146 – 1152Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001;16 (12): 1146 – 1152Kamsteeg EJ, Wormhoudt TA, Rijss JP et al. An impaired routing of wildtype aquaporin2 after tetramerization with an aquaporin2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 1999; 18(9): 2394 2400Kamsteeg EJ, Wormhoudt TA, Rijss JP et al. An impaired routing of wildtype aquaporin2 after tetramerization with an aquaporin2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 1999; 18(9): 2394 2400Mulder SM, Bichet DG, Rijss JP et al. An aquaporin2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998;102(1): 57 – 66Mulder SM, Bichet DG, Rijss JP et al. An aquaporin2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998;102(1): 57 – 66Marr N, Bichet DG, Lonergan M et al. Heteroligomerization of an aquaporin2 mutant with wildtype aquaporin2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 2002 11 (7): 779 – 789Marr N, Bichet DG, Lonergan M et al. Heteroligomerization of an aquaporin2 mutant with wildtype aquaporin2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 2002 11 (7): 779 – 789Kamsteeg EJ, Bichet DG, Konings IB et al. Reversed polarized delivery of an aquaporin2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol 2003; 163(5): 1099 – 1109Kamsteeg EJ, Bichet DG, Konings IB et al. Reversed polarized delivery of an aquaporin2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol 2003; 163(5): 1099 – 1109Miyakoshi M, Kamoi K, Uchida S, Sasaki S. A case of a novel mutant vasopressin receptordependent nephrogenic diabetes insipidus with bilateral nonobstructive hydronephrosis in a middle age man: differentiation from aquaporindependent nephrogenic diabetes insipidus by response of factor V111 and von Willebrand factor to 1diamino8arginine vasopressin administration. Endocr J 2003; (6): 809 – 814Miyakoshi M, Kamoi K, Uchida S, Sasaki S. A case of a novel mutant vasopressin receptordependent nephrogenic diabetes insipidus with bilateral nonobstructive hydronephrosis in a middle age man: differentiation from aquaporindependent nephrogenic diabetes insipidus by response of factor V111 and von Willebrand factor to 1diamino8arginine vasopressin administration. Endocr J 2003; (6): 809 – 814Van Lieburg AF, Knoers VV, Mallmann R et al. Normal fibrinolytic responses to 1desamino8arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin2 gene. Nephron 1996; 72 (4): 544 – 546Van Lieburg AF, Knoers VV, Mallmann R et al. Normal fibrinolytic responses to 1desamino8arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin2 gene. Nephron 1996; 72 (4): 544 – 546Kalenga K, Persu A, Goffin E et al. Intrafamilial phenotype variability in nephrogenic diabetes insipidus. Am J Kidney Dis 2002; 39(4): 737 – 743Kalenga K, Persu A, Goffin E et al. Intrafamilial phenotype variability in nephrogenic diabetes insipidus. Am J Kidney Dis 2002; 39(4): 737 – 743Ala Y, Morin D, Mouillac B et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998; 9(10): 1861 – 1872Ala Y, Morin D, Mouillac B et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998; 9(10): 1861 – 1872VargasPoussou R, Forestier L, Dautzenberg MD et al. Mutation in the vasopressin V2 receptor and aquaporin2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997; 8 (12): 1855 – 1862VargasPoussou R, Forestier L, Dautzenberg MD et al. Mutation in the vasopressin V2 receptor and aquaporin2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997; 8 (12): 1855 – 1862Rocha JL, Friedman E, Boson W et al. Molecular analyses of the vasopressin type 2 receptor amd aquaporin2 genes in Brazilian kinders with nephrogenic diabetes insipidus. Hum Mutat 1999; 14 (3): 233 – 239Rocha JL, Friedman E, Boson W et al. Molecular analyses of the vasopressin type 2 receptor amd aquaporin2 genes in Brazilian kinders with nephrogenic diabetes insipidus. Hum Mutat 1999; 14 (3): 233 – 239Nomura Y, Onigata K, Nagashima T et al. Detection of skewed Xinactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997; 82 (10): 3434 – 3437Nomura Y, Onigata K, Nagashima T et al. Detection of skewed Xinactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997; 82 (10): 3434 – 3437Van Lieburg AF, Verdijk MA, Schoute F et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 1995; 96 (1):70 – 78Van Lieburg AF, Verdijk MA, Schoute F et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 1995; 96 (1):70 – 78Sato K, Fukuno H, Taniguchi T et al. A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Intern Med 1999; 38 (10): 808 – 812Sato K, Fukuno H, Taniguchi T et al. A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Intern Med 1999; 38 (10): 808 – 812Pattaragrn A, Alon US. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase2 inhibitor. Pediatr Nephrol 2003; 18 (10): 1073 – 1076Pattaragrn A, Alon US. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase2 inhibitor. Pediatr Nephrol 2003; 18 (10): 1073 – 1076Van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and followup of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol – 1999; 10 (9): 1958 – 1964Van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and followup of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol – 1999; 10 (9): 1958 – 1964Mizuno H, Sugiyama Y, Ohro Y et al. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus. Endocrine 2004; 24(1): 55 – 59Mizuno H, Sugiyama Y, Ohro Y et al. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus. Endocrine 2004; 24(1): 55 – 59Shalev H, Romanovsky I, Knoers NV et al. Bladder function impairment in aquaporin2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 2004; 19 (3): 608 – 613Shalev H, Romanovsky I, Knoers NV et al. Bladder function impairment in aquaporin2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 2004; 19 (3): 608 – 613Glassberg KI. The valve bladder syndrome: 20 years later. J Urol 2001; 166 (4): 1406 – 1414Glassberg KI. The valve bladder syndrome: 20 years later. J Urol 2001; 166 (4): 1406 – 1414Fujii T, Ochi J, Miyajima T et al. Nephrogenic diabetes insipidus and tethered cord syndrome with a lipoma od the cauda. Brain Dev 1998; 20 (1): 47 – 49Fujii T, Ochi J, Miyajima T et al. Nephrogenic diabetes insipidus and tethered cord syndrome with a lipoma od the cauda. Brain Dev 1998; 20 (1): 47 – 49Minami J, On K, Inada H et al. A case of congenital nephrogenic diabetes insipidus accompanied by hypertension. Nippon Jinzo Gakkai Shi 2001; 43 (1): 35 – 38Minami J, On K, Inada H et al. A case of congenital nephrogenic diabetes insipidus accompanied by hypertension. Nippon Jinzo Gakkai Shi 2001; 43 (1): 35 – 38Owada M, Kawamura M, Kimura Y et al. Water intake and 24hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene. Intern Med 2002; 41 (2): 119 – 123Owada M, Kawamura M, Kimura Y et al. Water intake and 24hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene. Intern Med 2002; 41 (2): 119 – 123Hoekstra JA, van Lieburg AF, Monnens LA et al. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996; 61(1): 81 – 88Hoekstra JA, van Lieburg AF, Monnens LA et al. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996; 61(1): 81 – 88Konoshita T, Kuroda M, Kawane T et al. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient. Horm Res 2004; 61, (2): 63 – 67Konoshita T, Kuroda M, Kawane T et al. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient. Horm Res 2004; 61, (2): 63 – 67Kirchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 1999; 80(6): 548 – 552Kirchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 1999; 80(6): 548 – 552Mizuno H., Fujimoto S., Sugiyama Y et al. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 2003; 59(6): 297 – 300Mizuno H., Fujimoto S., Sugiyama Y et al. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 2003; 59(6): 297 – 300Muller D, Marr N, Ankermann T et al. Desmopressin for noctural enuresis in nephrogenic diabetes insipidus. Lancet 2002; 359 (93305) (9): 495 – 497Muller D, Marr N, Ankermann T et al. Desmopressin for noctural enuresis in nephrogenic diabetes insipidus. Lancet 2002; 359 (93305) (9): 495 – 497Morello JP, PetajaRepo UE, Bichet DG, Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 2000; 21(12): 466 – 469Morello JP, PetajaRepo UE, Bichet DG, Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 2000; 21(12): 466 – 469Schneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996; 15 (6): 1283 – 1291Schneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996; 15 (6): 1283 – 1291
The authors declare that there are no conflicts of interest present.